Global Gene Therapy on Neurological Diseases Market Growth (Status and Outlook) 2021-2026

Global Gene Therapy on Neurological Diseases Market Growth (Status and Outlook) 2021-2026

According to this latest study, the 2021 growth of Gene Therapy on Neurological Diseases will have significant change from previous year. By the most conservative estimates of global Gene Therapy on Neurological Diseases market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Gene Therapy on Neurological Diseases market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy on Neurological Diseases market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Viral Gene Therapy
Non-viral Gene Therapy

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Clinic
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Biogen
Novartis
Sarepta Therapeutics

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gene Therapy on Neurological Diseases Market Size 2016-2026
2.1.2 Gene Therapy on Neurological Diseases Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Gene Therapy on Neurological Diseases Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Viral Gene Therapy
2.3 Gene Therapy on Neurological Diseases Market Size by Type
2.3.1 Global Gene Therapy on Neurological Diseases Market Size CAGR by Type
2.3.2 Global Gene Therapy on Neurological Diseases Market Size Market Share by Type (2016-2021)
2.4 Gene Therapy on Neurological Diseases Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Gene Therapy on Neurological Diseases Market Size by Application
2.5.1 Global Gene Therapy on Neurological Diseases Market Size CAGR by Application
2.5.2 Global Gene Therapy on Neurological Diseases Market Size Market Share by Application (2016-2021)
3 Gene Therapy on Neurological Diseases Market Size by Players
3.1 Gene Therapy on Neurological Diseases Market Size Market Share by Players
3.1.1 Global Gene Therapy on Neurological Diseases Revenue by Players (2019-2021E)
3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2019-2021E)
3.2 Global Gene Therapy on Neurological Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gene Therapy on Neurological Diseases by Regions
4.1 Gene Therapy on Neurological Diseases Market Size by Regions (2016-2021)
4.2 Americas Gene Therapy on Neurological Diseases Market Size Growth (2016-2021)
4.3 APAC Gene Therapy on Neurological Diseases Market Size Growth (2016-2021)
4.4 Europe Gene Therapy on Neurological Diseases Market Size Growth (2016-2021)
4.5 Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth (2016-2021)
5 Americas
5.1 Americas Gene Therapy on Neurological Diseases Market Size by Country (2016-2021)
5.2 Americas Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
5.3 Americas Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy on Neurological Diseases Market Size by Region (2016-2021)
6.2 APAC Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
6.3 APAC Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gene Therapy on Neurological Diseases by Country (2016-2021)
7.2 Europe Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
7.3 Europe Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gene Therapy on Neurological Diseases by Region (2016-2021)
8.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
8.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Gene Therapy on Neurological Diseases Market Forecast
10.1 Global Gene Therapy on Neurological Diseases Forecast by Regions (2021-2026)
10.1.1 Global Gene Therapy on Neurological Diseases Forecast by Regions (2021-2026)
10.1.2 Americas Gene Therapy on Neurological Diseases Forecast
10.1.3 APAC Gene Therapy on Neurological Diseases Forecast
10.1.4 Europe Gene Therapy on Neurological Diseases Forecast
10.1.5 Middle East & Africa Gene Therapy on Neurological Diseases Forecast
10.2 Americas Gene Therapy on Neurological Diseases Forecast by Countries (2021-2026)
10.2.1 United States Gene Therapy on Neurological Diseases Market Forecast
10.2.2 Canada Gene Therapy on Neurological Diseases Market Forecast
10.2.3 Mexico Gene Therapy on Neurological Diseases Market Forecast
10.2.4 Brazil Gene Therapy on Neurological Diseases Market Forecast
10.3 APAC Gene Therapy on Neurological Diseases Forecast by Region (2021-2026)
10.3.1 China Gene Therapy on Neurological Diseases Market Forecast
10.3.2 Japan Gene Therapy on Neurological Diseases Market Forecast
10.3.3 Korea Gene Therapy on Neurological Diseases Market Forecast
10.3.4 Southeast Asia Gene Therapy on Neurological Diseases Market Forecast
10.3.5 India Gene Therapy on Neurological Diseases Market Forecast
10.3.6 Australia Gene Therapy on Neurological Diseases Market Forecast
10.4 Europe Gene Therapy on Neurological Diseases Forecast by Country (2021-2026)
10.4.1 Germany Gene Therapy on Neurological Diseases Market Forecast
10.4.2 France Gene Therapy on Neurological Diseases Market Forecast
10.4.3 UK Gene Therapy on Neurological Diseases Market Forecast
10.4.4 Italy Gene Therapy on Neurological Diseases Market Forecast
10.4.5 Russia Gene Therapy on Neurological Diseases Market Forecast
10.5 Middle East & Africa Gene Therapy on Neurological Diseases Forecast by Region (2021-2026)
10.5.1 Egypt Gene Therapy on Neurological Diseases Market Forecast
10.5.2 South Africa Gene Therapy on Neurological Diseases Market Forecast
10.5.3 Israel Gene Therapy on Neurological Diseases Market Forecast
10.5.4 Turkey Gene Therapy on Neurological Diseases Market Forecast
10.5.5 GCC Countries Gene Therapy on Neurological Diseases Market Forecast
10.6 Global Gene Therapy on Neurological Diseases Forecast by Type (2021-2026)
10.7 Global Gene Therapy on Neurological Diseases Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy on Neurological Diseases Product Offered
11.1.3 Biogen Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy on Neurological Diseases Product Offered
11.2.3 Novartis Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Information
11.3.2 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Offered
11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Sarepta Therapeutics Main Business Overview
11.3.5 Sarepta Therapeutics Latest Developments
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook